Are you anticipating some sort of statewide or nationwide 'stay at home' quarantine to be issued?

Cancer

FILE - In this April 30, 2017, file photo, Alex Trebek speaks at the 44th annual Daytime Emmy Awards at the Pasadena Civic Center in Pasadena, Calif. Trebek marked his one-year battle against pancreatic cancer with candor about how hard it’s been and a vow to keep going. “I’d be lying if I said the journey had been an easy one. There have been some good days, but a lot of not-so-good days,” the longtime “Jeopardy!” host said in a video message posted online Wednesday, March 4, 2020. He’s joked with friends that “the cancer won’t kill me, the chemo treatments will,” Trebek said. (Photo by Chris Pizzello/Invision/AP, File)
March 04, 2020 - 3:22 pm

Trebek reaches 1-year mark in cancer fight with hope, candor

LOS ANGELES (AP) — Alex Trebek marked his one-year battle against pancreatic cancer with candor about how hard it’s been and a vow to keep going. “I’d be lying if I said the journey had been an easy one. There have been some good days, but a lot of not-so-good days,” the longtime “Jeopardy!” host...
Read More
FILE - In this April 30, 2017, file photo, Alex Trebek speaks at the 44th annual Daytime Emmy Awards at the Pasadena Civic Center in Pasadena, Calif. Trebek marked his one-year battle against pancreatic cancer with candor about how hard it’s been and a vow to keep going. “I’d be lying if I said the journey had been an easy one. There have been some good days, but a lot of not-so-good days,” the longtime “Jeopardy!” host said in a video message posted online Wednesday, March 4, 2020. He’s joked with friends that “the cancer won’t kill me, the chemo treatments will,” Trebek said. (Photo by Chris Pizzello/Invision/AP, File)
March 04, 2020 - 1:37 pm

Trebek reaches 1-year mark in cancer fight with hope, candor

LOS ANGELES (AP) — Alex Trebek marked his one-year battle against pancreatic cancer with candor about how hard it’s been and a vow to keep going. “I’d be lying if I said the journey had been an easy one. There have been some good days, but a lot of not-so-good days,” the longtime “Jeopardy!” host...
Read More
February 21, 2020 - 12:51 pm

Cancer-linked chemical found inside Kansas aircraft hangar

WICHITA, Kan. (AP) — More than 50 personnel at McConnell Air Force Base in Kansas may have been exposed to dangerous levels of a compound linked to cancer that was found inside an aircraft hangar last year, according to internal memos. Contamination by hexavalent chrominium, the subject of the case...
Read More
February 21, 2020 - 12:05 pm

Cancer-linked chemical found inside Kansas aircraft hanger

WICHITA, Kan. (AP) — More than 50 personnel at McConnell Air Force Base in Kansas may have been exposed to dangerous levels of a compound linked to cancer that was found inside an aircraft hangar last year, according to internal memos. Contamination by hexavalent chrominium, the subject of the case...
Read More
February 19, 2020 - 7:16 am

UK patient plays violin during unusual brain surgery

LONDON (AP) — Surgeons at King's College Hospital in London removed a brain tumor from a woman who played the violin during the procedure. Doctors for violinist Dagmar Turner, 53, mapped her brain before the surgery to identify areas that were active when she played the instrument and those...
Read More
This undated image provided by Eisai in August 2018 shows the company's Belviq medication. On Thursday, Feb. 13, 2020, the drug's maker, Japan’s Eisai Inc., said that it has agreed to voluntarily withdraw the weight loss drug at the request of the U.S. Food and Drug Administration, because of a slight increased risk of cancer. (Eisai via AP)
February 13, 2020 - 7:05 pm

Weight loss drug Belviq pulled from market over cancer risk

The maker of a weight loss drug pulled it from the market Thursday at the request of federal regulators, who said it posed a slight increased risk of cancer. Japan’s Eisai Inc. said it was voluntarily withdrawing the drug, Belviq. However, the company said in a statement that it disagreed with the...
Read More
This undated image provided by Eisai in August 2018 shows the company's Belviq medication. On Thursday, Feb. 13, 2020, the drug's maker, Japan’s Eisai Inc., said that it has agreed to voluntarily withdraw the weight loss drug at the request of the U.S. Food and Drug Administration, because of a slight increased risk of cancer. (Eisai via AP)
February 13, 2020 - 5:54 pm

Weight loss drug Belviq pulled from market over cancer risk

The maker of a weight loss drug pulled it from the market Thursday at the request of federal regulators, who said it posed an increased risk of cancer. Japan’s Eisai Inc., said it was voluntarily withdrawing the drug, Belviq. However, the company said in a statement that it disagreed with the U.S...
Read More
February 13, 2020 - 5:09 pm

Weight loss drug Belviq pulled from market over cancer risk

The weight loss drug Belviq is being pulled from the market because of a slight increased risk of cancer. The drug's maker, Japan’s Eisai Inc., said Thursday that it has agreed to voluntarily withdraw Belviq at the request of the U.S. Food and Drug Administration. However, the company said in a...
Read More
In this Monday, Feb. 3, 2020 photo, guest pose with a new logo for Livestrong at an event in Austin, Texas. The Livestrong cancer charity is on a mission to reinvent itself. It has survived a dramatic fall in contributions and donations since founder Lance Armstrong's performance-enhancing drug scandal. (AP Photo/Eric Gay)
February 11, 2020 - 2:07 pm

Charity founded by disgraced cyclist announces relaunch plan

AUSTIN, Texas (AP) — The cancer charity whose yellow wristbands became a global brand under founder Lance Armstrong is seeking to reinvent itself, years after donations and revenues crashed along with the disgraced cyclist's career. Armstrong was nowhere to be seen earlier this month during...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck is posting a 29% jump in fourth-quarter profit and it's spinning off its women's health division and other operations that churn out $6.5 billion in annual revenues. The drugmaker on Wednesday, Feb. 5, 2020 reported net income of $2.36 billion, up from $1.83 billion, a year earlier. (AP Photo/Seth Wenig, File)
February 05, 2020 - 2:59 pm

Merck to spin off assets with $6.5B in sales; 4Q profit up

Drugmaker Merck beat Wall Street's fourth-quarter profit expectations, but investors weren't as happy with the biggest move Merck's made in years: deciding to spin off its women's health division and other operations with $6.5 billion in annual revenues. The maker of cancer blockbuster Keytruda...
Read More

Pages